| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$96,894 ) |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089917 | Cathepsin-L mediated remodeling of the nuclear proteome | 000 | 1 | NIH | 11/13/2024 | $227,250 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2020 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS113257 | Isolation of GPR160 for biochemical analysis of the activation mechanism and development of a high throughput screening assay to identify small molecule inhibitors | 000 | 1 | NIH | 10/1/2024 | -$324,144 |
|
| Issue Date FY: 2024 ( Subtotal = $22,030,292 ) (Continued on the next page) |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK095112 | Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism | 000 | 7 | NIH | 6/13/2024 | $679,795 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AI180725 | Stem-like T cells as bioindicators and orchestrators of the disease process in MS and animal models | 000 | 1 | NIH | 8/12/2024 | $305,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089957 | Age, sex, hormonal status, and anti-inflammatory therapy for atherosclerosis | 000 | 1 | NIH | 7/18/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T32GM141602 | Pharmacological Sciences Training Grant | 000 | 3 | NIH | 8/13/2024 | $255,280 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI175438 | A Novel Human Virus in Patients with Cryptogenic Liver Disease | 001 | 2 | NIH | 8/1/2024 | $189,375 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01ES034383 | Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury | 000 | 3 | NIH | 7/12/2024 | $450,008 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL139554 | Structural enzymology of protein C | 001 | 7 | NIH | 6/20/2024 | $43,185 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03HD115731 | Noninvasive assessment of in vivo tissue loads following treatment of volumetric muscle loss | 000 | 1 | NIH | 8/7/2024 | $303,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30HL170694 | The Role of Plasmalogen Mitochondrial and Endothelial Antioxidant Properties in Sepsis | 000 | 2 | NIH | 8/23/2024 | $53,974 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High-Sensitivity Bruker Q-Band Elexsys E580 Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1,746,529 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High-Sensitivity Bruker Q-Band Elexsys E580 Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK131136 | Role of bile acid receptors FXR and TGR5 in preventing injury in short bowel syndrome | 000 | 4 | NIH | 7/25/2024 | $363,600 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | D1930852 | Nursing Workforce Diversity | 00 | 8 | HRSA | 6/10/2024 | $541,277 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03TR005223 | Conditional knock-in of Gnb3/Gngt2 in mouse rod photoreceptors | 000 | 1 | NIH | 7/24/2024 | $151,500 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 003 | 5 | NIH | 7/23/2024 | $511,779 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA261979 | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | 000 | 3 | NIH | 7/9/2024 | $458,752 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 001 | 2 | NIH | 5/15/2024 | $35,432 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 001 | 3 | NIH | 5/24/2024 | $66,759 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AR081270 | Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | 001 | 2 | NIH | 6/11/2024 | $40,152 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 002 | 5 | NIH | 6/11/2024 | $57,080 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 3 | NIH | 3/26/2024 | $602,131 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK122401 | SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION | 000 | 5 | NIH | 5/9/2024 | $327,240 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HL173848 | Introducing NanoProTEN, a novel approach for anticoagulation in patients with prothrombotic autoantibodies | 000 | 1 | NIH | 3/29/2024 | $227,250 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM129731 | Acquiring Nanoparticle Tracking Analysis System to Enhance Lab Productivity and Capability | 000 | 2 | NIH | 5/1/2024 | $98,046 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM154323 | Mechanism of homologous recombination driven by the intrinsically disordered domain of tumor suppressor PALB2 | 000 | 1 | NIH | 4/26/2024 | $303,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 001 | 5 | NIH | 5/15/2024 | $37,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 000 | 3 | NIH | 7/5/2024 | $394,314 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 002 | 6 | NIH | 6/13/2024 | $43,905 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 000 | 5 | NIH | 11/15/2023 | $340,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 6 | NIH | 4/16/2024 | $493,946 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA277436 | GPR160 antibody development for cancer treatment | 000 | 2 | NIH | 6/25/2024 | $168,212 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 01 | 1 | HRSA | 9/10/2024 | $1,742 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 02 | 1 | HRSA | 9/26/2024 | $0 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 8/21/2024 | $230,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 8/21/2024 | $770,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG087308 | Methods for treating aging-related cognitive decline and reducing risk of AD/ADRD by enhancing the endogenous expression of adropin | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 001 | 3 | NIH | 7/23/2024 | $31,815 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 002 | 3 | NIH | 8/6/2024 | $61,319 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AI175583 | Assembly mechanisms of Rous sarcoma virus intasomes. | 001 | 1 | NIH | 9/13/2024 | $46,298 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM155891 | Improving Artificial Intelligence Readiness of RNA Motif Data for Structure Analysis and Modeling | 000 | 1 | NIH | 9/19/2024 | $467,334 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 2 | NIH | 12/7/2023 | $52,694 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 001 | 2 | NIH | 4/29/2024 | $1,280 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AI175583 | Assembly mechanisms of Rous sarcoma virus intasomes. | 000 | 1 | NIH | 6/3/2024 | $416,684 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 000 | 3 | NIH | 4/9/2024 | $286,335 |
|
